1. A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy
by Nakisa Khorsand, Hilde A.M. Kooistra, Reinier M. van Hest, Pharm D, Nic J.G.M. Veeger, and Karina Meijer
Blood
Volume 122(21):
November 15, 2013
©2013 by American Society of Hematology

2. Median PCC dosage per study(arm).
Hilde A.M. Kooistra et al. Blood 2013;122:3639
©2013 by American Society of Hematology

3. Results on target INR and clinical outcome per strategy.
Results on target INR and clinical outcome per strategy. Estimated relative risks with 95% confidence intervals for the study period are shown. VTE: venous thromboembolism D: dabigatran R: rivaroxaban A: apixaban
Hilde A.M. Kooistra et al. Blood 2013;122:3639
©2013 by American Society of Hematology